Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza

  • Technology appraisal guidance
  • TA158
  • Published: 
Download guidance (PDF)

6 Recommendations for further research

6.1

Research is required into methods of delivering zanamivir to the under-5 age group and to establish the effectiveness of such treatment.

6.2

Research is required to develop options for prophylaxis of influenza in infants (under 12 months of age).